市場調査レポート
商品コード
1178540

抗バイオフィルム創傷被覆材の市場規模、シェア&動向分析レポート:メカニズム別(物理、化学、生物)、用途別(慢性創傷、急性創傷)、最終用途別、地域別、セグメント別予測、2023年~2030年

Anti-biofilm Wound Dressing Market Size, Share & Trends Analysis Report By Mode Of Mechanism (Physical, Chemical, Biological), By Application (Chronic Wounds, Acute Wounds), By End-use, By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 97 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
抗バイオフィルム創傷被覆材の市場規模、シェア&動向分析レポート:メカニズム別(物理、化学、生物)、用途別(慢性創傷、急性創傷)、最終用途別、地域別、セグメント別予測、2023年~2030年
出版日: 2022年12月01日
発行: Grand View Research
ページ情報: 英文 97 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

抗バイオフィルム創傷被覆材市場の成長と動向

Grand View Research, Inc.の最新レポートによると、抗バイオフィルム創傷被覆材の世界市場規模は、2023年から2030年にかけてCAGR 9.6%を記録し、2030年までに14億8000万米ドルに達すると予測されています。病院内感染(HAI)の発生率の上昇、慢性疾患の有病率の増加、熱傷患者の増加が市場の主要な促進要因となっています。

世界中で慢性疾患の有病率が上昇していることが、市場を牽引すると予想されます。例えば、国際糖尿病連合によると、糖尿病の世界の有病率は、2011年の3億6,600万人から2030年には5億5,200万人に増加すると予想されています。糖尿病の長期化は糖尿病性足潰瘍につながるため、糖尿病の有病率の上昇は予測期間中の市場成長にプラスの影響を与えると予想されます。抗バイオフィルム創傷被覆材は、慢性的な傷の治癒に非常に効果的であるため、この要因が製品の需要を促進すると予想されます。さらに、世界中で老年人口が増加していることも、市場の成長を急増させると予想されています。例えば、世界保健機関(WHO)によると、世界の老年人口は2016年の9,000万人から2050年には20億人に増加すると予想されています。老年人口は慢性疾患や潰瘍にかかりやすいため、老年人口の増加も市場の成長を押し上げると予想されます。

事故や火傷などの外傷の増加が市場成長に寄与すると予想されます。外傷は、高所得国に比べて低・中所得国で多く見られます。全世界で約50.00%の人々が火災に関連する外傷にさらされています。例えば、WHOによると、毎年100万人以上が中度または重度の火傷を負っていると報告されています。したがって、このような火傷の症例数の増加が製品の需要を押し上げ、予測期間中の市場成長を促進すると予測されます。

抗バイオフィルム創傷被覆材市場レポートハイライト

収益面では、2019年にメカニズムの化学的モードセグメントが最大のシェアを占めました。慢性および急性の傷害における銀製抗バイオフィルム創傷被覆材の使用の増加が、セグメントを推進する主要因である

全世界で外科手術の数が増加しているため、急性創傷セグメントが2019年に最大の市場シェアを占めた

アジア太平洋地域は、手術件数の増加と多くの現地プレイヤーの存在により、予測期間中に最も速い成長を示すと予想されます。

目次

第1章 調査範囲

  • 市場セグメンテーションと範囲
  • 地域範囲

第2章 調査手法

  • 調査手法
    • 情報調達
  • 情報またはデータ分析
  • 市場の策定と検証
  • 地域別の市場計算
    • 地域別市場:基本推定
    • 世界市場:CAGR計算
  • 地域別セグメントシェア計算
  • モデルの詳細
    • コモディティフロー分析(モデル1)
    • ボリューム価格分析(モデル2)
  • 二次情報一覧

第3章 目的

第4章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し
  • 競合考察
  • 市場のスナップショット

第5章 業界の見通し

  • 浸透と成長の見通しのマッピング
  • 規制の枠組み
  • 市場力学
    • 市場促進要因分析
      • 慢性および急性創傷の有病率の増加
      • 外来手術センターの増加
      • 事故や火傷、外傷の増加
      • 手術件数の急増
    • 市場抑制要因分析
      • 治療費の高騰
      • 代替の高度な創傷ケアドレッシング材の使用の増加
  • 抗バイオフィルム創傷被覆材市場分析ツール
    • PEST別SWOT分析
    • ポーターのファイブフォース分析
  • COVID-110の影響
    • サプライチェーン
    • 変化する市場動向

第6章 抗バイオフィルム創傷被覆材市場:セグメント分析、メカニズム別、2018年から2030年(100万米ドル)

  • 定義と範囲
  • メカニズムのモード市場シェア分析、2022年および2030年
  • 抗バイオフィルム創傷被覆材市場、メカニズム別、2018年から2030年
  • 市場規模予測とトレンド分析
    • 物理的
      • 手動デブリードマン
      • パルス電場
      • 超音波デブリードマン
    • 化学
      • イオン銀
      • ヨウ素
      • EDTA
      • その他
    • 生物学的
      • ディスパーシンB
      • ラクトフェリン
      • バクテリオファージ
      • その他

第7章 抗バイオフィルム創傷被覆材市場:セグメント分析、アプリケーション別、2018年から2030年(100万米ドル)

  • 定義と範囲
  • アプリケーション市場シェア分析、2022年および2030年
  • 抗バイオフィルム創傷被覆材市場、アプリケーション別、2018年から2030年
  • 市場規模予測とトレンド分析
    • 慢性創傷
      • 糖尿病性足潰瘍
      • 褥瘡
      • 静脈性下肢潰瘍
      • その他の慢性創傷
    • 急性創傷
      • 外科的および外傷性創傷
      • 火傷

第8章 慢性創傷ケア市場:セグメント分析、最終用途別、2018年から2030年(100万米ドル)

  • 定義と範囲
  • 最終用途の市場シェア分析、2021年および2030年
  • 2018年から2030年までの最終用途別の世界の慢性創傷ケア市場
  • 市場規模の予測とトレンド分析
    • 病院
    • 専門クリニック
    • 在宅ヘルスケア
    • その他

第9章 抗バイオフィルム創傷被覆材市場:メカニズムとアプリケーションのモード別の地域市場分析、2018年から2030年(100万米ドル)

  • 定義と範囲
  • 地域市場シェア分析、2022年および2030年
  • 地域市場のスナップショット
  • 市場規模の予測とトレンド分析
    • 北米
      • 米国
      • カナダ
    • 欧州
      • 英国
      • ドイツ
      • フランス
      • イタリア
      • スペイン
      • スウェーデン
      • ノルウェー
      • デンマーク
    • アジア太平洋地域
      • 日本
      • 中国
      • インド
      • オーストラリア
      • 韓国
      • タイ
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • アルゼンチン
    • 中東とアフリカ
      • 南アフリカ
      • サウジアラビア
      • アラブ首長国連邦
      • クウェート

第10章 抗バイオフィルム創傷被覆材市場:競合分析

  • 企業プロファイル
    • ConvaTec Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Smith &Nephew PLC
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Urgo Medical
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Coloplast
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • 3M
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Molnlycke Health Care AB
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Imbed Biosciences
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Next Science
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • B. Braun Melsungen AG
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Lohmann &Rauscher
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
図表

List of Tables

  • Table 1 Primary interview details: North America
  • Table 2 Primary interview details: Europe
  • Table 3 Primary interview details: APAC
  • Table 4 Primary interview details: Latin America
  • Table 5 Primary interview details: MEA
  • Table 6 List of secondary sources
  • Table 7 List of abbreviations
  • Table 8 North America anti-biofilm wound dressing market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 10 North America anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.S anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 13 U.S. anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 14 U.S. anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Canada anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 16 Canada anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 17 Canada anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Europe anti-biofilm wound dressing market, by country, 2018 - 2030 (USD Million)
  • Table 19 Europe anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 20 Europe anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 21 Europe anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 U.K. anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 23 U.K. anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 24 U.K. anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Germany anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 26 Germany anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 27 Germany anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 France anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 29 France anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 30 France anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Italy anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 32 Italy anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 33 Italy anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Spain anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 35 Spain anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 36 Spain anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Sweden anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 38 Sweden anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Denmark anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 41 Denmark anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 42 Denmark anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Norway anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 44 Norway anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 45 Norway anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific anti-biofilm wound dressing market, by country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Japan anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 51 Japan anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 52 Japan anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 China anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 54 China anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 55 China anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 India anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 57 India anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 58 India anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Australia anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 60 Australia anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 South Korea anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 63 South Korea anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 64 South Korea anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Thailand anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 66 Thailand anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 67 Thailand anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 68 Latin America anti-biofilm wound dressing market, by country, 2018 - 2030 (USD Million)
  • Table 69 Latin America anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 70 Latin America anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 71 Latin America anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Brazil anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 73 Brazil anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 74 Brazil anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Mexico anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 76 Mexico anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 77 Mexico anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Argentina anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 79 Argentina anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 80 Argentina anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa anti-biofilm wound dressing market, by country, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 South Africa anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 86 Table 40 South Africa anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 87 South Africa anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 UAE anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 92 UAE anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 93 UAE anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)
  • Table 94 Kuwait anti-biofilm wound dressing market, by mode of mechanism, 2018 - 2030 (USD Million)
  • Table 95 Kuwait anti-biofilm wound dressing market, by application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait anti-biofilm wound dressing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Anti-biofilm wound dressing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market summary (2022)
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Reimbursement pathway
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Anti-biofilm wound dressing market: Mode of mechanism movement analysis
  • Fig. 17 Anti-biofilm wound dressing market mode of mechanism outlook: Key takeaways
  • Fig. 18 Physical market, 2018 - 2030 (USD Million)
  • Fig. 19 Manual debridement market, 2018 - 2030 (USD Million)
  • Fig. 20 Pulse electrical field market, 2018 - 2030 (USD Million)
  • Fig. 21 Ultrasound debridement market, 2018 - 2030 (USD Million)
  • Fig. 22 Chemical market, 2018 - 2030 (USD Million)
  • Fig. 23 Ionic silver market, 2018 - 2030 (USD Million)
  • Fig. 24 Iodine market, 2018 - 2030 (USD Million)
  • Fig. 25 EDTA market, 2018 - 2030 (USD Million)
  • Fig. 26 Others market, 2018 - 2030 (USD Million)
  • Fig. 27 Biological market, 2018 - 2030 (USD Million)
  • Fig. 28 Dispersin B market, 2018 - 2030 (USD Million)
  • Fig. 29 Lactoferrin market, 2018 - 2030 (USD Million)
  • Fig. 30 Bacteriophage market, 2018 - 2030 (USD Million)
  • Fig. 31 Others market, 2018 - 2030 (USD Million)
  • Fig. 32 Anti-biofilm wound dressing market: Application movement analysis
  • Fig. 33 Anti-biofilm wound dressing market application outlook: Key takeaways
  • Fig. 34 Chronic wounds market, 2018 - 2030 (USD Million)
  • Fig. 35 Diabetic foot ulcers market, 2018 - 2030 (USD Million)
  • Fig. 36 Pressure ulcers market, 2018 - 2030 (USD Million)
  • Fig. 37 Venous leg ulcers market, 2018 - 2030 (USD Million)
  • Fig. 38 Other chronic wounds market, 2018 - 2030 (USD Million)
  • Fig. 39 Acute wounds market, 2018 - 2030 (USD Million)
  • Fig. 40 Surgical & traumatic wounds market, 2018 - 2030 (USD Million)
  • Fig. 41 Burn wounds market, 2018 - 2030 (USD Million)
  • Fig. 42 Anti-biofilm wound dressing market: End-use movement analysis
  • Fig. 43 Anti-biofilm wound dressing market end-use outlook: Key takeaways
  • Fig. 44 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 45 Specialty clinics market, 2018 - 2030 (USD Million)
  • Fig. 46 Home healthcare market, 2018 - 2030 (USD Million)
  • Fig. 47 Others market, 2018 - 2030 (USD Million)
  • Fig. 48 Regional Outlook, 2022 & 2030
  • Fig. 49 Regional market: Key takeaways
  • Fig. 50 North America anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 51 U.S. anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 52 Canada anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 53 Europe anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 54 UK anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 55 Germany anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 56 France anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 57 Italy anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 58 Spain anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 59 Sweden anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 60 Denmark anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 61 Norway anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 62 Asia Pacific anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 63 Japan anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 64 China anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 65 India anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 66 Australia anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 67 South Korea anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 69 Latin America anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 70 Brazil anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 71 Mexico anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 72 Argentina anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 73 Middle East & Africa anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 75 Saudi Arabia anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 76 UAE anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
  • Fig. 77 Kuwait anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68038-948-7

Anti-biofilm Wound Dressing Market Growth & Trends:

The global anti-biofilm wound dressing market size is expected to reach USD 1.48 billion by 2030, registering a CAGR of 9.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising incidence of Hospital Acquired Infections (HAIs), the growing prevalence of chronic diseases, and the increasing number of burn cases are the key driving factors for the market.

Increasing the prevalence of chronic diseases across the globe is anticipated to drive the market. For instance, as per the International Diabetes Federation, the global prevalence of diabetes is expected to increase from 366.0 million in 2011 to 552.0 million by 2030. Since prolonged diabetes leads to diabetic foot ulcers, thus, the rising prevalence of diabetes is expected to render a positive impact on market growth over the forecast period. The anti-biofilm wound dressing is very much effective in healing chronic injuries, thus, this factor is expected to propel the demand for the product. Furthermore, the increasing geriatric population across the globe is also anticipated to surge the market growth. For instance, as per the World Health Organization (WHO), the global geriatric population is anticipated to rise from 90.0 million in 2016 to 2.0 billion by 2050. Since the geriatric population is prone to chronic diseases and ulcers, thus growing geriatric population is also expected to surge in market growth.

Increasing cases of accidents and trauma such as burns are expected to contribute to market growth. Traumatic events are most common in low and middle-income countries in comparison to high-income countries. Around 50.00% of people globally are exposed to fire-related traumas. For instance, as per the WHO, over 1,000,000 people are registered, annually, as moderately or severely burnt. Therefore, such an increase in the number of burn cases is projected to boost the demand for the products, thereby propelling the market growth over the forecast period.

Anti-biofilm Wound Dressing Market Report Highlights:

  • In terms of revenue, the chemical mode of the mechanism segment held the largest share in 2019. An increase in the use of silver anti-biofilm wound dressing in chronic and acute injuries is the major factor driving the segment
  • The acute wounds segment held the largest market share in 2019 owing to the rising number of surgical procedures across the globe
  • Asia Pacific is anticipated to witness the fastest growth over the forecast period owing to the rising number of surgeries and the presence of many local players.

Table of Contents

Chapter 1 Report Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Regional Scope
  • 1.3 Estimates and Forecast Timeline

Chapter 2 Research Methodology

  • 2.1 Research Methodology
    • 2.1.1 Information procurement
  • 2.2 Information or Data Analysis
  • 2.3 Market Formulation & Validation
  • 2.4 Region-Wise Market Calculation
    • 2.4.1 Region-Wise Market: Base Estimates
    • 2.4.2 Global Market: CAGR Calculation
  • 2.5 Region-Based Segment Share Calculation
  • 2.6 Model Details
    • 2.6.1 Commodity Flow Analysis (Model 1)
    • 2.6.2 Volume price analysis (Model 2)
  • 2.7 List of Secondary Sources

Chapter 3 Objectives

  • 3.1 Objective - 1:
  • 3.2 Objective - 2:
  • 3.3 Objective - 3:
  • 3.4 Objective - 4:

Chapter 4 Executive Summary

  • 4.1 Market Outlook
  • 4.2 Segment Outlook
  • 4.3 Competitive Insights
  • 4.4 Market Snapshot

Chapter 5 Industry Outlook

  • 5.1 Penetration & Growth Prospect Mapping
  • 5.2 Regulatory Framework
  • 5.3 Market Dynamics
    • 5.3.1 Market driver analysis
      • 5.3.1.1 Increasing prevalence of chronic and acute wounds
      • 5.3.1.2 Rising number of ambulatory surgery centers
      • 5.3.1.3 Increasing number of accidents, burn injuries, and trauma cases
      • 5.3.1.4 Surge in the number of surgeries
    • 5.3.2 Market restraint analysis
      • 5.3.2.1 Rising treatment costs
      • 5.3.2.2 Increasing usage of alternative advanced wound care dressings
  • 5.4 Anti-biofilm Wound Dressing Market Analysis Tools
    • 5.4.1 SWOT Analysis, by PEST
    • 5.4.2 Porter's Five Forces analysis
  • 5.5 Impact of COVID-110
    • 5.5.1 Supply chain
    • 5.5.2 Changing market trends

Chapter 6 Anti-biofilm Wound Dressing Market: Segment Analysis, By Mode of Mechanism, 2018 - 2030 (USD Million)

  • 6.1 Definitions & Scope
  • 6.2 Mode of Mechanism Market Share Analysis, 2022 & 2030
  • 6.3 Anti-biofilm Wound Dressing Market, by Mode of Mechanism, 2018 to 2030
  • 6.4 Market Size Forecasts and Trend Analysis
    • 6.4.1 Physical
      • 6.4.1.1 Physical market, 2018 - 2030 (USD Million)
      • 6.4.1.2 Manual debridement
      • 6.4.1.2.1 Manual debridement market, 2018 - 2030 (USD Million)
      • 6.4.1.3 Pulse electrical field
      • 6.4.1.3.1 Pulse electrical field market, 2018 - 2030 (USD Million)
      • 6.4.1.4 Ultrasound debridement
      • 6.4.1.4.1 Ultrasound debridement market, 2018 - 2030 (USD Million)
    • 6.4.2 Chemical
      • 6.4.2.1 Chemical market, 2018 - 2030 (USD Million)
      • 6.4.2.2 Ionic silver
      • 6.4.2.2.1 Ionic silver market, 2018 - 2030 (USD Million)
      • 6.4.2.3 Iodine
      • 6.4.2.3.1 Iodine market, 2018 - 2030 (USD Million)
      • 6.4.2.4 EDTA
      • 6.4.2.4.1 EDTA market, 2018 - 2030 (USD Million)
      • 6.4.2.5 Others
      • 6.4.2.5.1 Others market, 2018 - 2030 (USD Million)
    • 6.4.3 Biological
      • 6.4.3.1 Biological market, 2018 - 2030 (USD Million)
      • 6.4.3.2 Dispersin B
      • 6.4.3.2.1 Dispersin B market, 2018 - 2030 (USD Million)
      • 6.4.3.3 Lactoferrin
      • 6.4.3.3.1 Lactoferrin market, 2018 - 2030 (USD Million)
      • 6.4.3.4 Bacteriophage
      • 6.4.3.4.1 Bacteriophage market, 2018 - 2030 (USD Million)
      • 6.4.3.5 Others
      • 6.4.3.5.1 Others market, 2018 - 2030 (USD Million)

Chapter 7 Anti-biofilm Wound Dressing Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 7.1 Definitions & Scope
  • 7.2 Application Market Share Analysis, 2022 & 2030
  • 7.3 Anti-biofilm Wound Dressing Market, by Application, 2018 to 2030
  • 7.4 Market Size Forecasts and Trend Analysis
    • 7.4.1 Chronic wounds
      • 7.4.1.1 Chronic wounds market, 2018 - 2030 (USD Million)
      • 7.4.1.2 Diabetic foot ulcers
      • 7.4.1.2.1 Diabetic foot ulcers market, 2018 - 2030 (USD Million)
      • 7.4.1.3 Pressure ulcers
      • 7.4.1.3.1 Pressure ulcers market, 2018 - 2030 (USD Million)
      • 7.4.1.4 Venous leg ulcers
      • 7.4.1.4.1 Venous leg ulcers market, 2018 - 2030 (USD Million)
      • 7.4.1.5 Other chronic wounds
      • 7.4.1.5.1 Other chronic wounds market, 2018 - 2030 (USD Million)
    • 7.4.2 Acute wounds
      • 7.4.2.1 Acute wounds market, 2018 - 2030 (USD Million)
      • 7.4.2.2 Surgical & traumatic wounds
      • 7.4.2.2.1 Surgical & traumatic wounds market, 2018 - 2030 (USD Million)
      • 7.4.2.3 Burn wounds
      • 7.4.2.3.1 Burn wounds market, 2018 - 2030 (USD Million)

Chapter 8 Chronic Wound Care Market: Segment Analysis, By End-use, 2018 - 2030 (USD Million)

  • 8.1 Definitions & Scope
  • 8.2 End-use Market Share Analysis, 2021 & 2030
  • 8.3 Global Chronic Wound Care Market, by End-use, 2018 to 2030
  • 8.4 Market Size Forecasts & Trend Analysis
    • 8.4.1 Hospitals
      • 8.4.1.1 Hospitals market, 2018 - 2030 (USD Million)
    • 8.4.2 Specialty Clinics
      • 8.4.2.1 Specialty clinics market, 2018 - 2030 (USD Million)
    • 8.4.3 Home Healthcare
      • 8.4.3.1 Home healthcare market, 2018 - 2030 (USD Million)
    • 8.4.4 Others
      • 8.4.4.1 Others market, 2018 - 2030 (USD Million)

Chapter 9 Anti-biofilm Wound Dressing Market: Regional Market Analysis, By Mode of Mechanism and Application, 2018 - 2030 (USD Million)

  • 9.1 Definitions & Scope
  • 9.2 Regional Market Share Analysis, 2022 & 2030
  • 9.3 Regional Market Snapshot
  • 9.4 Market Size Forecasts & Trend Analysis
    • 9.4.1 North America
      • 9.4.1.1 North America anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.1.2 U.S.
      • 9.4.1.2.1 U.S. anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.1.3 Canada
      • 9.4.1.3.1 Canada anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
    • 9.4.2 Europe
      • 9.4.2.1 Europe anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.2.2 U.K.
      • 9.4.2.2.1 U.K. anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.2.3 Germany
      • 9.4.2.3.1 Germany anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.2.4 France
      • 9.4.2.4.1 France anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.2.5 Italy
      • 9.4.2.5.1 Italy anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.2.6 Spain
      • 9.4.2.6.1 Spain anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.2.7 Sweden
      • 9.4.2.7.1 Sweden anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.2.8 Norway
      • 9.4.2.8.1 Norway anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.2.9 Denmark
      • 9.4.2.9.1 Denmark anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
    • 9.4.3 Asia Pacific
      • 9.4.3.1 Asia Pacific anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.3.2 Japan
      • 9.4.3.2.1 Japan anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.3.3 China
      • 9.4.3.3.1 China anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.3.4 India
      • 9.4.3.4.1 India anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.3.5 Australia
      • 9.4.3.5.1 Australia anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.3.6 South Korea
      • 9.4.3.6.1 South Korea anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.3.7 Thailand
      • 9.4.3.7.1 Thailand anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
    • 9.4.4 Latin America
      • 9.4.4.1 Latin America anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.4.2 Brazil
      • 9.4.4.2.1 Brazil anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.4.3 Mexico
      • 9.4.4.3.1 Mexico anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.4.3 Argentina
      • 9.4.4.3.1 Argentina anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
    • 9.4.5 Middle East & Africa
      • 9.4.5.1 Middle East & Africa anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.5.2 South Africa
      • 9.4.5.2.1 South Africa anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.5.3 Saudi Arabia
      • 9.4.5.3.1 Saudi Arabia anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.5.4 UAE
      • 9.4.5.4.1 UAE anti-biofilm wound dressing market, 2018 - 2030 (USD Million)
      • 9.4.5.5 Kuwait
      • 9.4.5.5.1 Kuwait anti-biofilm wound dressing market, 2018 - 2030 (USD Million)

Chapter 10 Anti-biofilm Wound Dressing Market: Competitive Analysis

  • 10.1 Company Profiles
    • 10.1.1 ConvaTec Inc.
      • 10.1.1.1 Company overview
      • 10.1.1.2 Financial performance
      • 10.1.1.3 Product benchmarking
      • 10.1.1.4 Strategic initiatives
    • 10.1.2 Smith & Nephew PLC
      • 10.1.2.1 Company overview
      • 10.1.2.2 Financial performance
      • 10.1.2.3 Product benchmarking
      • 10.1.2.4 Strategic initiatives
    • 10.1.3 Urgo Medical
      • 10.1.3.1 Company overview
      • 10.1.3.2 Financial performance
      • 10.1.3.3 Product benchmarking
      • 10.1.3.4 Strategic initiatives
    • 10.1.4 Coloplast
      • 10.1.4.1 Company overview
      • 10.1.4.2 Financial performance
      • 10.1.4.3 Product benchmarking
      • 10.1.4.4 Strategic initiatives
    • 10.1.5 3M
      • 10.1.5.1 Company overview
      • 10.1.5.2 Financial performance
      • 10.1.5.3 Product benchmarking
      • 10.1.5.4 Strategic initiatives
    • 10.1.6 Molnlycke Health Care AB
      • 10.1.6.1 Company overview
      • 10.1.6.2 Financial performance
      • 10.1.6.3 Product benchmarking
      • 10.1.6.4 Strategic initiatives
    • 10.1.7 Imbed Biosciences
      • 10.1.7.1 Company overview
      • 10.1.7.2 Financial performance
      • 10.1.7.3 Product benchmarking
      • 10.1.7.4 Strategic initiatives
    • 10.1.8 Next Science
      • 10.1.8.1 Company overview
      • 10.1.8.2 Financial performance
      • 10.1.8.3 Product benchmarking
      • 10.1.8.4 Strategic initiatives
    • 10.1.9 B. Braun Melsungen AG
      • 10.1.9.1 Company overview
      • 10.1.9.2 Financial performance
      • 10.1.9.3 Product benchmarking
      • 10.1.9.4 Strategic initiatives
    • 10.1.10 Lohmann & Rauscher
      • 10.1.10.1 Company overview
      • 10.1.10.2 Financial performance
      • 10.1.10.3 Product benchmarking
      • 10.1.10.4 Strategic initiatives